Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate

• Status: No longer available
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate whether anecortave acetate can slow or stop the progression of age-related macular degeneration in patients who do not qualify for other studies and have no other treatment options.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Iowa
• Treatments: Anecortave

Criteria

Inclusion Criteria:

• Choroidal neovascularization, mostly occult

• Visual acuity > 20/40 in study eye

Exclusion Criteria:

• Allergy to fluorescein dye

• Inability to stop warfarin prior to treatment

• Pregnancy

• Other serious ocular diseases or conditions